ENVISTA HOLDINGS CORP (NVST): Price and Financial Metrics
ENVISTA HOLDINGS CORP (NVST)
Today's Latest Price: $30.07 USD
Updated Dec 1 6:40pm
Add NVST to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 143 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
NVST Stock Summary
- NVST's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.51 -- higher than merely 6.17% of US-listed equities with positive expected earnings growth.
- NVST's went public 1.21 years ago, making it older than only 1.15% of listed US stocks we're tracking.
- With a year-over-year growth in debt of 48.93%, Envista Holdings Corp's debt growth rate surpasses 81.31% of about US stocks.
- Stocks that are quantitatively similar to NVST, based on their financial statements, market capitalization, and price volatility, are NUVA, INOD, VSTO, STRT, and Y.
- Visit NVST's SEC page to see the company's official filings. To visit the company's web site, go to www.envistaco.com.
NVST Stock Price Chart Interactive Chart >
NVST Price/Volume Stats
| Current price | $30.07 | 52-week high | $33.30 |
| Prev. close | $29.73 | 52-week low | $10.08 |
| Day low | $29.82 | Volume | 800,500 |
| Day high | $30.61 | Avg. volume | 2,434,209 |
| 50-day MA | $26.91 | Dividend yield | N/A |
| 200-day MA | $22.19 | Market Cap | 4.80B |
ENVISTA HOLDINGS CORP (NVST) Company Bio
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The firm operates through the following segments; Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018 and is headquartered in Brea, CA.
NVST Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $30.07 | $1.36 | -95% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Envista Holdings Corp. To summarize, we found that Envista Holdings Corp ranked in the 7th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 95%. As for the metrics that stood out in our discounted cash flow analysis of Envista Holdings Corp, consider:
- The company's compound free cash flow growth rate over the past 1.15 years comes in at -0.27%; that's greater than only 5.45% of US stocks we're applying DCF forecasting to.
- Envista Holdings Corp's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
- The weighted average cost of capital for the company is 11. This value is greater than 86.26% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -95% |
| 1% | -95% |
| 2% | -95% |
| 3% | -95% |
| 4% | -95% |
| 5% | -95% |
LUMO, VREX, OSMT, COO, and EW can be thought of as valuation peers to NVST, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...